Physician Wealth Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$599 Buy
7
+2
+40% +$209 ﹤0.01% 2143
2026
Q2
$586 Buy
+5
New +$502 ﹤0.01% 2033
2025
Q2
– Sell
-17
Closed -$766 – 1913
2025
Q1
$766 Buy
+17
New +$801 ﹤0.01% 1249

Other funds holding MIRM

Physician Wealth Advisors's MIRM Position: Q3 2026 in Review

Physician Wealth Advisors increased its Mirum Pharmaceuticals (MIRM) stake by 40% in Q3 2026, buying an estimated $209 and bringing the position to 7 shares worth $599. The position accounts for ﹤0.01% of the portfolio, ranked #2143.

Physician Wealth Advisors first reported a position in MIRM in Q1 2025 and has held it in 3 quarters since. The position peaked at $766 in Q1 2025. 317 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Physician Wealth Advisors held 7 shares of Mirum Pharmaceuticals worth $599 as of Q3 2026.
  • Physician Wealth Advisors bought 2 Mirum Pharmaceuticals shares in Q3 2026, an estimated $209.
  • Mirum Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #2143 holding.
  • Physician Wealth Advisors first reported a position in Mirum Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • Physician Wealth Advisors's Mirum Pharmaceuticals position peaked at $766 in Q1 2025.
  • 317 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.